{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:31:21Z","timestamp":1793266281671,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011338","name":"Hunan Normal University Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["25JCLMJC00290"],"award-info":[{"award-number":["25JCLMJC00290"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004517","name":"Tianjin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004517","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.109657","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:13:28Z","timestamp":1790694808000},"page":"109657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nanomedicine design strategy for preferential elimination of cancer stem cells by targeted HIF-Warburg-immune evasion axis: Systematic review"],"prefix":"10.1016","volume":"233","author":[{"given":"Lili","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqin","family":"kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0455-0969","authenticated-orcid":false,"given":"Yubo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.109657_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.126588","article-title":"Targeting cancer stem cells: Dual-drug delivery systems and their role in cancer therapy","volume":"691","author":"Yin","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib2","article-title":"Advanced drug delivery platforms target cancer stem cells","volume":"20","author":"Mazloomi","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2026.109657_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2026.1807649","article-title":"Metabolic reprogramming and plasticity of cancer stem cells","volume":"14","author":"Kulus","year":"2026","journal-title":"Front. Cell. Dev. Biol."},{"issue":"23","key":"10.1016\/j.phrs.2026.109657_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235912","article-title":"Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy","volume":"14","author":"Papadaki","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12935-023-03169-1","article-title":"The emerging role of glycolysis and immune evasion in gastric cancer","volume":"23","author":"Zheng","year":"2023","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.phrs.2026.109657_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2025.05.003","article-title":"Advances in the mechanisms of HIF-1\u03b1-enhanced tumor glycolysis and its relation to dedifferentiation","volume":"197","author":"Zeng","year":"2025","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"19","key":"10.1016\/j.phrs.2026.109657_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911943","article-title":"Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.109657_bib8","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4161\/cc.10.11.15659","article-title":"Evidence for a stromal-epithelial \"lactate shuttle\" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts","volume":"10","author":"Whitaker-Menezes","year":"2011","journal-title":"Cell. Cycle"},{"issue":"8","key":"10.1016\/j.phrs.2026.109657_bib10","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1073\/pnas.1018866109","article-title":"Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia","volume":"109","author":"Conley","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.phrs.2026.109657_bib11","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1158\/0008-5472.CAN-06-1010","article-title":"Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor","volume":"66","author":"Bao","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.109657_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123015","article-title":"Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion","volume":"355","author":"Sarabia-S\u00e1nchez","year":"2024","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.phrs.2026.109657_bib13","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s12015-025-10956-y","article-title":"Metabolic Plasticity and Cancer Stem Cell Metabolism: Exploring the Glycolysis-OXPHOS Switch as a Mechanism for Resistance and Tumorigenesis","volume":"21","author":"Keoh","year":"2025","journal-title":"Stem Cell. Rev. Rep."},{"key":"10.1016\/j.phrs.2026.109657_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1741800","article-title":"Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications","volume":"13","author":"Psvv","year":"2026","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.phrs.2026.109657_bib15","first-page":"1","article-title":"I - Stimuli-responsive nanomaterials as modulators of cancer stem cell fate: current progress and future perspectives","volume":"L","author":"U - Zhu","year":"2026","journal-title":"- 1 S"},{"issue":"20","key":"10.1016\/j.phrs.2026.109657_bib16","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","article-title":"Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy","volume":"18","author":"Meijer","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.15252\/embj.201695204","article-title":"Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype","volume":"36","author":"Semenza","year":"2017","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.phrs.2026.109657_bib18","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.7150\/thno.33100","article-title":"Endocytosis-mediated mitochondrial transplantation: Transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity","volume":"9","author":"Sun","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.109657_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113861","article-title":"Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy","volume":"156","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"23","key":"10.1016\/j.phrs.2026.109657_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239125","article-title":"Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer","volume":"21","author":"El-Sahli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.109657_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/cns-2015-0006","article-title":"Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept","volume":"5","author":"Yuen","year":"2016","journal-title":"CNS Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","article-title":"Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.phrs.2026.109657_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib26","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.109657_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040992","article-title":"Hypoxia-Driven Immune Escape in the Tumor Microenvironment","volume":"9","author":"Vito","year":"2020","journal-title":"Cells"},{"issue":"35","key":"10.1016\/j.phrs.2026.109657_bib28","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/onc.2013.390","article-title":"Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner","volume":"33","author":"Lim","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2026.109657_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110623","article-title":"Hypoxia-mediated cancer stem cell resistance and targeted therapy","volume":"130","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib30","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3892\/ijo.2017.3924","article-title":"2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1alpha\/PDK1 axis","volume":"50","author":"Zhao","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"22","key":"10.1016\/j.phrs.2026.109657_bib31","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","article-title":"Lactate: a metabolic key player in cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.phrs.2026.109657_bib32","doi-asserted-by":"crossref","first-page":"19456","DOI":"10.18632\/oncotarget.3318","article-title":"Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.phrs.2026.109657_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4161\/cbt.26726","article-title":"AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway","volume":"15","author":"Sanli","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib34","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.0902584","article-title":"Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes","volume":"184","author":"Dietl","year":"2010","journal-title":"J. Immunol."},{"issue":"7519","key":"10.1016\/j.phrs.2026.109657_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2026.109657_bib36","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2026.109657_bib37","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41419-021-04124-6","article-title":"Notch1\/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer","volume":"12","author":"Xie","year":"2021","journal-title":"Cell. Death Dis."},{"issue":"12","key":"10.1016\/j.phrs.2026.109657_bib38","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and Toll-like receptor signaling balance T(reg) cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial Metabolism as a Target for Cancer Therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell. Metab."},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib40","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/0008-5472.CAN-20-3730","article-title":"Oncometabolites in Cancer: Current Understanding and Challenges","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.phrs.2026.109657_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122900","article-title":"Metabolic Rewiring and the Characterization of Oncometabolites","volume":"13","author":"Beyoglu","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"29","key":"10.1016\/j.phrs.2026.109657_bib42","doi-asserted-by":"crossref","first-page":"46692","DOI":"10.18632\/oncotarget.8727","article-title":"Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents","volume":"7","author":"Corrado","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.109657_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2016.04.025","article-title":"Oncometabolites: Unconventional triggers of oncogenic signalling cascades","volume":"100","author":"Sciacovelli","year":"2016","journal-title":"Free. Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and Implications of Metabolic Heterogeneity in Cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell. Metab."},{"issue":"12","key":"10.1016\/j.phrs.2026.109657_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121927","article-title":"Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells","volume":"9","author":"Ha","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.phrs.2026.109657_bib46","article-title":"Oncometabolites: A new insight for oncology","volume":"7","author":"Khatami","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"issue":"6487","key":"10.1016\/j.phrs.2026.109657_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbcan.2018.06.005","article-title":"Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect","volume":"1870","author":"Sun","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13050618","article-title":"Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies","volume":"13","author":"Nadhan","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib50","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-derived lactic acid modulates dendritic cell activation and antigen expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.phrs.2026.109657_bib51","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib52","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26383","article-title":"Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology","volume":"2","author":"Husain","year":"2013","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib53","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/cac2.12607","article-title":"Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma","volume":"44","author":"Cai","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.phrs.2026.109657_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fimmu.2014.00024","article-title":"Metabolic influences that regulate dendritic cell function in tumors","volume":"5","author":"Dong","year":"2014","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib55","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ijc.28114","article-title":"Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity","volume":"133","author":"Ohashi","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell. Metab."},{"issue":"6527","key":"10.1016\/j.phrs.2026.109657_bib57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.109657_bib58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jconrel.2021.05.034","article-title":"Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy","volume":"335","author":"Xia","year":"2021","journal-title":"J. Control. Release"},{"issue":"6614","key":"10.1016\/j.phrs.2026.109657_bib59","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.abj5104","article-title":"Oncometabolite d-2HG alters T cell metabolism to impair CD8(+) T cell function","volume":"377","author":"Notarangelo","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2026.109657_bib60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12967-020-02267-2","article-title":"Comprehensive analysis of the association between tumor glycolysis and immune\/inflammation function in breast cancer","volume":"18","author":"Li","year":"2020","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib62","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"issue":"19","key":"10.1016\/j.phrs.2026.109657_bib63","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.109657_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2012.00089","article-title":"Irradiation promotes an m2 macrophage phenotype in tumor hypoxia","volume":"2","author":"Chiang","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.109657_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1089446","article-title":"Hypoxia-responsive nanomaterials for tumor imaging and therapy","volume":"12","author":"Xia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.109657_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132940","article-title":"Self-activating chitosan-based nanoparticles for sphingosin-1 phosphate modulator delivery and selective tumor therapy","volume":"272","author":"Mahmudi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib67","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","article-title":"Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors","volume":"28","author":"Jones","year":"2021","journal-title":"Cell. Stem Cell."},{"issue":"23","key":"10.1016\/j.phrs.2026.109657_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235912","article-title":"Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy","volume":"14","author":"Papadaki","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.phrs.2026.109657_bib69","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1873-3468.13686","article-title":"Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3\/Akt\/mTOR pathway in colon cancer","volume":"594","author":"Kim","year":"2020","journal-title":"Febs Lett."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1039\/D3LC00804E","article-title":"Dielectrophoretic enrichment of live chemo-resistant circulating-like pancreatic cancer cells from media of drug-treated adherent cultures of solid tumors","volume":"24","author":"Rane","year":"2024","journal-title":"Lab. Chip"},{"issue":"8","key":"10.1016\/j.phrs.2026.109657_bib71","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","article-title":"Influencing factors and strategies of enhancing nanoparticles into tumors","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.phrs.2026.109657_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071804","article-title":"Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood-Brain Barrier to Treat Brain Tumors","volume":"15","author":"Vanbilloen","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2026.109657_bib73","article-title":"Pharmacokinetics and tumor delivery of nanoparticles","volume":"83","author":"Yuan","year":"2023","journal-title":"J. Drug. Deliv. Sci. Tec."},{"key":"10.1016\/j.phrs.2026.109657_bib74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.05.036","article-title":"State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines","volume":"187","author":"Dawidczyk","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2026.109657_bib75","first-page":"991","article-title":"Insights into the therapeutic potential of hypoxia-inducible factor-1\u03b1 small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes","volume":"11","author":"Chen","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2026.109657_bib76","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jconrel.2015.11.017","article-title":"pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery","volume":"220","author":"Zhu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2026.109657_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2014.12.028","article-title":"Co-delivery of HIF1alpha siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer","volume":"46","author":"Zhao","year":"2015","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib78","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1039\/C4TB01442A","article-title":"Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth","volume":"3","author":"Choi","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.phrs.2026.109657_bib79","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.colsurfb.2017.09.039","article-title":"Preparation of artificial red cell and its application on alleviation of tumor hypoxia","volume":"160","author":"Qu","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"10","key":"10.1016\/j.phrs.2026.109657_bib80","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1039\/C9BM00797K","article-title":"Enhancement of cisplatin efficacy by lipid-CaO(2) nanocarrier-mediated comprehensive modulation of the tumor microenvironment","volume":"7","author":"He","year":"2019","journal-title":"Biomater. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2026.109657_bib81","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1021\/acsnano.8b02977","article-title":"Normalizing Tumor Microenvironment Based on Photosynthetic Abiotic\/Biotic Nanoparticles","volume":"12","author":"Zheng","year":"2018","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib82","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1021\/acsabm.1c00938","article-title":"Self-Remedied Nanomedicine for Surmounting the Achilles' Heel of Photodynamic Tumor Therapy","volume":"4","author":"Zhou","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"7","key":"10.1016\/j.phrs.2026.109657_bib83","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.biomaterials.2013.11.076","article-title":"Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment","volume":"35","author":"Gao","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.phrs.2026.109657_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106010","article-title":"Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation\/Chemodynamic \/Immunotherapy","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib85","doi-asserted-by":"crossref","first-page":"22102","DOI":"10.1038\/s41598-021-01284-5","article-title":"Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression","volume":"11","author":"Rauca","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib86","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1021\/acsnano.2c10893","article-title":"Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib87","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12951-022-01752-8","article-title":"Acidic and hypoxic tumor microenvironment regulation by CaO(2)-loaded polydopamine nanoparticles","volume":"20","author":"Ruan","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.phrs.2026.109657_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121516","article-title":"Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy","volume":"284","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib89","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1038\/s41467-024-53084-w","article-title":"Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy and immunotherapy","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.phrs.2026.109657_bib90","doi-asserted-by":"crossref","first-page":"27651","DOI":"10.1021\/acsami.2c05533","article-title":"Designing Lactate Dehydrogenase-Mimicking SnSe Nanosheets To Reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy","volume":"14","author":"Ling","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12951-023-01949-5","article-title":"Oral membrane-biomimetic nanoparticles for enhanced endocytosis and regulation of tumor-associated macrophage","volume":"21","author":"Gu","year":"2023","journal-title":"J. Nanobiotechnology"},{"issue":"51","key":"10.1016\/j.phrs.2026.109657_bib92","doi-asserted-by":"crossref","first-page":"48261","DOI":"10.1021\/acsami.9b18112","article-title":"Oxygen-Self-Supplying and HIF-1\u03b1-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy","volume":"11","author":"Liu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"13","key":"10.1016\/j.phrs.2026.109657_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33837","article-title":"CaCO(3)-Encapsulated polydopamine with an adsorbed TLR7 agonist for improved tumor photothermal immunotherapy","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"28","key":"10.1016\/j.phrs.2026.109657_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201801120","article-title":"A Multifunctional Biomimetic Nanoplatform for Relieving Hypoxia to Enhance Chemotherapy and Inhibit the PD-1\/PD-L1 Axis","volume":"14","author":"Zou","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.phrs.2026.109657_bib95","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1038\/ncomms6988","article-title":"Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor","volume":"6","author":"Liu","year":"2015","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2026.109657_bib96","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1021\/acsabm.1c00667","article-title":"Ultra-Small Platinum Nanoparticle-Enabled Catalysis and Corrosion Susceptibility Reverse Tumor Hypoxia for Cancer Chemoimmunotherapy","volume":"4","author":"Liao","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"38","key":"10.1016\/j.phrs.2026.109657_bib97","doi-asserted-by":"crossref","first-page":"15431","DOI":"10.1073\/pnas.1204600109","article-title":"Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine","volume":"109","author":"Kang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib98","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1021\/acsnano.2c12685","article-title":"Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.phrs.2026.109657_bib99","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","article-title":"STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity","volume":"21","author":"Dane","year":"2022","journal-title":"Nat. Mater."},{"issue":"14","key":"10.1016\/j.phrs.2026.109657_bib100","doi-asserted-by":"crossref","first-page":"13158","DOI":"10.1021\/acsnano.2c12123","article-title":"Glucose Transporter 1-Mediated Transcytosis of Glucosamine-Labeled Liposomal Ceramide Targets Hypoxia Niches and Cancer Stem Cells to Enhance Therapeutic Efficacy","volume":"17","author":"Yu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2026.109657_bib101","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2016.03.045","article-title":"Challenges and opportunities for siRNA-based cancer treatment","volume":"387","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.phrs.2026.109657_bib102","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1021\/acsnano.7b03037","article-title":"Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response","volume":"11","author":"Yong","year":"2017","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.phrs.2026.109657_bib103","article-title":"Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor","volume":"12","author":"Liu","year":"2016","journal-title":"Nanomed. -Nanotechnol."},{"issue":"4","key":"10.1016\/j.phrs.2026.109657_bib104","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11899-019-00530-y","article-title":"Targeting Translation of mRNA as a Therapeutic Strategy in Cancer","volume":"14","author":"Pal","year":"2019","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.phrs.2026.109657_bib105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejmech.2012.01.033","article-title":"Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors","volume":"49","author":"Xia","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"51","key":"10.1016\/j.phrs.2026.109657_bib106","doi-asserted-by":"crossref","first-page":"48261","DOI":"10.1021\/acsami.9b18112","article-title":"Oxygen-Self-Supplying and HIF-1\u03b1-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy","volume":"11","author":"Liu","year":"2019","journal-title":"Acs Appl. Mater. Inter."},{"issue":"10","key":"10.1016\/j.phrs.2026.109657_bib107","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1021\/acs.nanolett.6b02365","article-title":"Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies","volume":"16","author":"Song","year":"2016","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.phrs.2026.109657_bib108","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijpharm.2015.01.009","article-title":"V: Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors","volume":"479","author":"Danhier","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2026.109657_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119177","article-title":"Paclitaxel-in-liposome-in-bacteria for inhalation treatment of primary lung cancer","volume":"578","author":"Zhang","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/acsnano.0c00042","article-title":"Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1alpha Inhibitor Impairs Pancreatic Tumor Growth","volume":"14","author":"Lang","year":"2020","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.phrs.2026.109657_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024075","article-title":"Therapeutic efficacy and safety of paclitaxel\/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer","volume":"6","author":"Milane","year":"2011","journal-title":"PLoS. One"},{"issue":"7","key":"10.1016\/j.phrs.2026.109657_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070965","article-title":"Targeting Cancer Stem Cells in Triple-Negative Breast Cancer","volume":"11","author":"Park","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.phrs.2026.109657_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106010","article-title":"Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation\/Chemodynamic \/Immunotherapy","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2026.109657_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120935","article-title":"NIR-II fluorescence imaging guided tumor-specific NIR-II photothermal therapy enhanced by starvation mediated thermal sensitization strategy","volume":"275","author":"Dai","year":"2021","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.phrs.2026.109657_bib115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/bjc.2016.255","article-title":"Transforming growth factor \u03b2 as regulator of cancer stemness and metastasis","volume":"115","author":"Bellomo","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2026.109657_bib116","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell-immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"10.1016\/j.phrs.2026.109657_bib117","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1089\/scd.2011.0660","article-title":"The cancer stem cell subtype determines immune infiltration of glioblastoma","volume":"21","author":"Beier","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.phrs.2026.109657_bib118","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/hep.30630","article-title":"A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib119","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma cancer stem cells induce immunosuppressive macrophages\/microglia","volume":"12","author":"Wu","year":"2010","journal-title":"Neuro Oncol."},{"issue":"14","key":"10.1016\/j.phrs.2026.109657_bib120","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1158\/0008-5472.CAN-18-2659","article-title":"MicroRNA-92 Expression in CD133(+) Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGF\u03b2","volume":"79","author":"Shidal","year":"2019","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib121","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1158\/1535-7163.MCT-09-0734","article-title":"Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway","volume":"9","author":"Wei","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"51","key":"10.1016\/j.phrs.2026.109657_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904639","article-title":"Intra\/Extracellular Lactic Acid Exhaustion for Synergistic Metabolic Therapy and Immunotherapy of Tumors","volume":"31","author":"Gao","year":"2019","journal-title":"Adv. Mater."},{"issue":"38","key":"10.1016\/j.phrs.2026.109657_bib123","doi-asserted-by":"crossref","first-page":"15431","DOI":"10.1073\/pnas.1204600109","article-title":"Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C (OH) and its implication for de novo design of nanomedicine","volume":"109","author":"Kang","year":"2012","journal-title":"P Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.109657_bib124","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1021\/acsabm.1c00667","article-title":"Ultra-Small Platinum Nanoparticle-Enabled Catalysis and Corrosion Susceptibility Reverse Tumor Hypoxia for Cancer Chemoimmunotherapy","volume":"8","author":"Liao","year":"2021","journal-title":"ACS Appl. bio Mater."},{"key":"10.1016\/j.phrs.2026.109657_bib125","article-title":"CaCO3-Encapsulated polydopamine with an adsorbed TLR7 agonist for improved tumor photothermal immunotherapy","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"13","key":"10.1016\/j.phrs.2026.109657_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310913","article-title":"Polymer-Functionalized Mitochondrial Transplantation to Fibroblasts Counteracts a Pro-Fibrotic Phenotype","volume":"24","author":"Baudo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.109657_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122953","article-title":"A precision intelligent nanomissile for inhibiting tumor metastasis, boosting energy deprivation and immunotherapy","volume":"315","author":"Gao","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib128","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13287-026-05014-4","article-title":"The metabolic profiles of cancer stem cells","volume":"17","author":"Tylichova","year":"2026","journal-title":"Stem Cell. Res. & Ther."},{"key":"10.1016\/j.phrs.2026.109657_bib130","first-page":"19","article-title":"Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch","author":"Aisu","year":"2024","journal-title":"PLOS ONE"},{"key":"10.1016\/j.phrs.2026.109657_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/cells15121107","article-title":"Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives","volume":"15","author":"Huang","year":"2026","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.phrs.2026.109657_bib132","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1\u03b1 Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells","volume":"22","author":"Sancho","year":"2015","journal-title":"Cell. Metab."},{"issue":"7524","key":"10.1016\/j.phrs.2026.109657_bib133","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib134","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell. Stem Cell."},{"issue":"9","key":"10.1016\/j.phrs.2026.109657_bib135","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/iub.1426","article-title":"The metabolic landscape of cancer stem cells","volume":"67","author":"Dando","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phrs.2026.109657_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.preme.2026.100076","article-title":"Emerging Nanomaterials for Activation of the cGAS\u2013STING Pathway in Cancer Immunotherapy","author":"He","year":"2026","journal-title":"Precis. Med. Eng."},{"issue":"17","key":"10.1016\/j.phrs.2026.109657_bib137","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.7150\/thno.100036","article-title":"Harnessing glucose metabolism with nanomedicine for cancer treatment","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2026.109657_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00001","article-title":"Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy","volume":"8","author":"Qin","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib139","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative Phosphorylation as an Emerging Target in Cancer Therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2026.109657_bib141","article-title":"Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.109657_bib142","article-title":"Targeting hypoxia-inducible factor 1\u03b1 in chronic graft-versus-host disease to enhance graft-versus-leukemia responses: implications for nanotherapeutics","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib143","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12935-025-03698-x","article-title":"The emerging role of glycolysis and immune evasion in ovarian cancer","volume":"25","author":"Jin","year":"2025","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib144","article-title":"pH-responsive CDs-based nanoplatform for chemo-resistant esophageal cancer treatment via downregulation of HIF-1\u03b1 related pathway","volume":"24","author":"Wang","year":"2026","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.phrs.2026.109657_bib145","doi-asserted-by":"crossref","unstructured":"Hou H., Li X.: Design of a pH-Responsive Cu-Doped nanoplatform for Down-Regulating HIF-1\u03b1 and enhancing Esophageal cancer chemotherapy. Materials & Design 2026.","DOI":"10.1016\/j.matdes.2026.115981"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib146","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s13287-022-03180-9","article-title":"Targeting cancer stem cells with polymer nanoparticles for gastrointestinal cancer treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Stem Cell. Res. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib147","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03984-w","article-title":"Nanomedicine-enabled disruption of glucose metabolism and synergistic antitumor therapy","volume":"24","author":"Ni","year":"2026","journal-title":"J. Nanobiotechnology"},{"issue":"12","key":"10.1016\/j.phrs.2026.109657_bib148","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.18632\/oncotarget.2010","article-title":"Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation","volume":"5","author":"Past\u00f2","year":"2014","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib149","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/stem.2286","article-title":"Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program","volume":"34","author":"Aguilar","year":"2016","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.phrs.2026.109657_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003284","article-title":"Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response","volume":"23","author":"Qiu","year":"2025","journal-title":"PLoS. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109657_bib151","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O'Brien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.109657_bib152","article-title":"Glycolysis in the tumor microenvironment shapes dendritic cell function and antitumor immunity","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib153","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-019-0752-z","article-title":"HIF Inhibitors: Status of Current Clinical Development","volume":"21","author":"Fallah","year":"2019","journal-title":"Curr. Oncol. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2026.109657_bib154","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1574892811666160415160104","article-title":"Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents","volume":"11","author":"Sheng","year":"2016","journal-title":"Recent. Pat. Anticancer. Drug. Discov."},{"issue":"10","key":"10.1016\/j.phrs.2026.109657_bib155","article-title":"Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccin. (Basel)"},{"issue":"2","key":"10.1016\/j.phrs.2026.109657_bib156","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/nnm.13.204","article-title":"Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine","volume":"9","author":"Xue","year":"2014","journal-title":"Nanomed. (Lond. )"},{"key":"10.1016\/j.phrs.2026.109657_bib157","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3762\/bjnano.16.10","article-title":"Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy","volume":"16","author":"Sukubo","year":"2025","journal-title":"Beilstein J. Nanotechnol."},{"issue":"20","key":"10.1016\/j.phrs.2026.109657_bib158","doi-asserted-by":"crossref","first-page":"28536","DOI":"10.1021\/acsami.6c05213","article-title":"Lipid Nanoparticle Surface Engineering with Heparosan Polysaccharides for Safe and Effective mRNA Delivery In Vitro and In Vivo","volume":"18","author":"He","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2026.109657_bib159","article-title":"Cardiotoxicity Challenges in Nanomaterial: Risk Assessment, Mechanisms, and Mitigation Strategies","volume":"21","author":"Li","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.phrs.2026.109657_bib160","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/17435889.2025.2476377","article-title":"Designing nanoparticles to minimize unintended inflammatory responses: a step toward safer and more effective precision nanomedicine","volume":"20","author":"Yuan","year":"2025","journal-title":"Nanomed. (Lond. )"},{"key":"10.1016\/j.phrs.2026.109657_bib161","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/IJN.S442877","article-title":"Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment","volume":"19","author":"Han","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"21","key":"10.1016\/j.phrs.2026.109657_bib162","article-title":"Nanocarrier-Based Delivery Systems for Natural Compounds Across Research Stages","volume":"18","author":"Antonelli","year":"2025","journal-title":"Mater. (Basel)"},{"issue":"1","key":"10.1016\/j.phrs.2026.109657_bib163","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-026-04727-y","article-title":"Nanotechnology based topical drug delivery systems for psoriasis addressing current strategies clinical progress and manufacturing challenges","volume":"21","author":"Bhoyar","year":"2026","journal-title":"Discov. Nano"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826015720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:31:25Z","timestamp":1793262685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826015720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":163,"alternative-id":["S1043661826015720"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109657","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine design strategy for preferential elimination of cancer stem cells by targeted HIF-Warburg-immune evasion axis: Systematic review","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109657"}}